Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices.